LendingClub Receives NYSE Notice of Delisting for Failure to Meet Continued Listing Rule
LendingClub Corp filed an 8-K on June 2, 2026 disclosing that the New York Stock Exchange has notified the company it no longer satisfies a continued listing requirement. The notice initiates a standard NYSE cure process that will determine whether the company's common stock can remain listed.
foxbusiness.comLendingClub Corp received a notice from the New York Stock Exchange on or about June 2, 2026 stating that the company is not in compliance with a continued listing rule, according to an 8-K filed with the SEC that same day.
The filing, submitted under Item 3.01, identifies the specific listing standard violated but does not publicly detail the exact rule in the summary disclosure. Item 7.01 contains Regulation FD disclosure related to the notice. LendingClub's common stock trades under the ticker LC on the NYSE.
The NYSE notice triggers a cure period during which LendingClub must submit a plan to regain compliance. If the NYSE accepts the plan, the company will be subject to a monitoring period. Failure to regain compliance within the prescribed timeframe will result in the stock being delisted and moving to over-the-counter trading.
Operationally, the company remains listed while the cure process runs. The filing does not alter LendingClub's day-to-day lending operations or its status as a publicly reporting company with the SEC. A separate Form 8-K would be required if the NYSE reaches a final determination to delist the shares or if the company appeals any decision.
Downstream, the company must respond to the NYSE within the exchange's deadline, typically 45 days for many deficiencies, although the exact cure window depends on the rule cited. Acceptance of a compliance plan would subject LendingClub to quarterly monitoring and potential accelerated delisting if milestones are missed.
If delisted, the stock would trade on OTC markets, which typically reduces liquidity, narrows the investor base, and can affect the company's ability to raise capital on listed-market terms. The company must also consider any contractual impacts, such as debt covenants or equity incentive plans that reference NYSE listing status.
This marks the first public disclosure by LendingClub of a NYSE continued-listing deficiency since at least the company's 2014 initial public offering. The 8-K includes exhibits detailing the notice letter as required under Item 9.01.
Coverage spread
Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.
No mainstream coverage of this story has surfaced yet.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Related Stories
thehindu.comU.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect
A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.
prnewswire.comFed Chairman Names Two Outside Advisers During Transition
Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.
insidermonkey.comForte Biosciences Accepts Resignation of Director David Veitch
Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…